A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux - PubMed (original) (raw)

Review

. 2016 Nov;273(11):3795-3801.

doi: 10.1007/s00405-016-4142-y. Epub 2016 Jun 16.

Affiliations

• PMID: 27312992
• DOI: 10.1007/s00405-016-4142-y

Review

A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux

Chunhui Wei. Eur Arch Otorhinolaryngol. 2016 Nov.

Abstract

We aimed to systematically review the randomized controlled trials (RCTs) regarding the therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngeal reflux (LPR). Randomized and placebo-controlled trials regarding the therapeutic efficacy of PPIs on LPR patients were systematically searched from MEDLINE, Cochrane Library, and EMBASE. Data were extracted from eligible studies meeting the inclusion criteria. Heterogeneity among these eligible studies was evaluated by the Q-statistic and I 2 test, based on which a fixed- or random-effects model was performed to pooled relative risks (RRs) for the response rate and standardized mean differences (SMDs) for reflux symptom index (RSI) and the reflux finding score (RFS). Potential publication bias was evaluated by trim and fill method. Totally, 13 RCTs including 831 LPR patients were eligible for this meta-analysis. Pooled results demonstrated that the total RSI significantly improved for patients who received PPI therapy by comparing with those receiving placebo (SMD = 3.65; 95 % CI 1.56-5.75), though no significant difference was found in response rate (RR = 0.04, 95 % CI -0.06 to 0.14) and RFS (SMD = 0.91; 95 % CI -0.53 to 2.35) between these two groups of patients. No publication bias was found among eligible studies. PPI treatment could significantly improve reflux symptoms in LPR patients and, therefore, should be taken into consideration for LPR management with other strategies, such as lifestyle modification.

Keywords: Laryngopharyngeal reflux; Meta-analysis; Proton pump inhibitor.

PubMed Disclaimer

Similar articles

• Proton Pump Inhibitor Therapy for the Treatment of Laryngopharyngeal Reflux: A Meta-Analysis of Randomized Controlled Trials.
  Guo H, Ma H, Wang J. Guo H, et al. J Clin Gastroenterol. 2016 Apr;50(4):295-300. doi: 10.1097/MCG.0000000000000324. J Clin Gastroenterol. 2016. PMID: 25906028
• Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux.
  Liu C, Wang H, Liu K. Liu C, et al. Braz J Med Biol Res. 2016 Jul 4;49(7):e5149. doi: 10.1590/1414-431X20165149. Braz J Med Biol Res. 2016. PMID: 27383119 Free PMC article. Review.
• Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux.
  Agrawal N, Yadlapati R, Shabeeb N, Price CP, Lidder A, Shintani-Smith S, Bové M, Pandolfino J, Tan B. Agrawal N, et al. Dis Esophagus. 2019 Apr 1;32(4):doy072. doi: 10.1093/dote/doy072. Dis Esophagus. 2019. PMID: 30101358
• Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
  Lee YC, Lee JS, Kim SW, Kwon KH, Eun YG. Lee YC, et al. JAMA Otolaryngol Head Neck Surg. 2013 Dec;139(12):1291-5. doi: 10.1001/jamaoto.2013.5556. JAMA Otolaryngol Head Neck Surg. 2013. PMID: 24201320
• A systematic review of proton-pump inhibitor therapy for laryngopharyngeal reflux.
  Megwalu UC. Megwalu UC. Ear Nose Throat J. 2013 Aug;92(8):364-71. doi: 10.1177/014556131309200811. Ear Nose Throat J. 2013. PMID: 23975490 Review.

Cited by

• Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update.
  Durazzo M, Lupi G, Cicerchia F, Ferro A, Barutta F, Beccuti G, Gruden G, Pellicano R. Durazzo M, et al. J Clin Med. 2020 Aug 7;9(8):2559. doi: 10.3390/jcm9082559. J Clin Med. 2020. PMID: 32784573 Free PMC article. Review.
• Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.
  Pizzorni N, Ambrogi F, Eplite A, Rama S, Robotti C, Lechien J, Schindler A. Pizzorni N, et al. Eur Arch Otorhinolaryngol. 2022 May;279(5):2533-2542. doi: 10.1007/s00405-021-07219-0. Epub 2022 Jan 15. Eur Arch Otorhinolaryngol. 2022. PMID: 35032204 Free PMC article. Clinical Trial.
• Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
  Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Scarpignato C, et al. BMC Med. 2016 Nov 9;14(1):179. doi: 10.1186/s12916-016-0718-z. BMC Med. 2016. PMID: 27825371 Free PMC article. Review.
• Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?
  Targownik L. Targownik L. Am J Gastroenterol. 2018 Apr;113(4):519-528. doi: 10.1038/ajg.2018.29. Epub 2018 Mar 20. Am J Gastroenterol. 2018. PMID: 29557943 Review.
• Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.
  Wilson JA, Stocken DD, Watson GC, Fouweather T, McGlashan J, MacKenzie K, Carding P, Karagama Y, Harries M, Ball S, Khwaja S, Costello D, Wood R, Lecouturier J, O'Hara J. Wilson JA, et al. Health Technol Assess. 2021 Jan;25(3):1-118. doi: 10.3310/hta25030. Health Technol Assess. 2021. PMID: 33492208 Free PMC article. Clinical Trial.

References

1. 1. Clin Otolaryngol. 2006 Feb;31(1):20-4; discussion 24 - PubMed
2. 1. Otolaryngol Head Neck Surg. 2011 Dec;145(6):974-80 - PubMed
3. 1. Clin Gastroenterol Hepatol. 2010 Sep;8(9):770-6 - PubMed
4. 1. Otolaryngol Head Neck Surg. 2007 Feb;136(2):205-10 - PubMed
5. 1. Laryngoscope. 2001 Dec;111(12):2147-51 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations